{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:41:00Z","timestamp":1782333660090,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP\/00041 and PI19\/00144"],"award-info":[{"award-number":["CP\/00041 and PI19\/00144"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201821-30-31-32"],"award-info":[{"award-number":["201821-30-31-32"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert Koch Institute","award":["1369-341"],"award-info":[{"award-number":["1369-341"]}]},{"name":"Ministerio de Ciencia en Innovacion","award":["RTI2018-099773-B-100"],"award-info":[{"award-number":["RTI2018-099773-B-100"]}]},{"DOI":"10.13039\/100010434","name":"\u201cla Caixa\u201d Foundation","doi-asserted-by":"publisher","award":["HR18-00452"],"award-info":[{"award-number":["HR18-00452"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"crossref","award":["POCTEFA 2014-2020"],"award-info":[{"award-number":["POCTEFA 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beatriu de Pin\u00f3s GenCat","award":["2018-BP-00129"],"award-info":[{"award-number":["2018-BP-00129"]}]},{"name":"CERCA Programme of Generalitat de Catalunya"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00415-020-09870-9","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T18:02:53Z","timestamp":1588701773000},"page":"2567-2581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid \u03b2-amyloid42, total-tau, phospho-tau and \u03b1-synuclein in the differential diagnosis of neurodegenerative dementia"],"prefix":"10.1007","volume":"267","author":[{"given":"Daniela","family":"Diaz-Lucena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge\u00f2rgia","family":"Escaramis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villar-Piqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Varges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eul\u00e0lia","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Baldeiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-7497","authenticated-orcid":false,"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"9870_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1440-1789.2005.00605.x","volume":"25","author":"RA Armstrong","year":"2005","unstructured":"Armstrong RA, Lantos PL, Cairns NJ (2005) Overlap between neurodegenerative disorders. Neuropathology 25:111\u2013124","journal-title":"Neuropathology"},{"key":"9870_CR2","doi-asserted-by":"crossref","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement [Internet] 7(3):263\u2013269. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21514250%5Cn, https:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC3312024","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"9870_CR3","doi-asserted-by":"crossref","unstructured":"Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S et al (2018) Validation and utilization of amended diagnostic criteria in Creutzfeldt\u2013Jakob disease surveillance. Neurology. https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000005860","DOI":"10.1212\/WNL.0000000000005860"},{"issue":"Pt 10","key":"9870_CR4","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease. Brain 132(Pt 10):2659\u20132668","journal-title":"Brain"},{"issue":"4","key":"9870_CR5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","volume":"53","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Ebert E, Stoeck K, Karch A, Collins S, Calero M et al (2016) Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt\u2013Jakob disease diagnostic. Mol Neurobiol 53(4):2189\u20132199","journal-title":"Mol Neurobiol"},{"issue":"3","key":"9870_CR6","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt\u2013Jakob disease. Mol Neurobiol 53(3):1896\u20131904","journal-title":"Mol Neurobiol"},{"issue":"5","key":"9870_CR7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","volume":"12","author":"F Llorens","year":"2016","unstructured":"Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K et al (2016) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimer\u2019s Dement 12(5):577\u2013589","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"9870_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","volume":"78","author":"NSM Schoonenboom","year":"2012","unstructured":"Schoonenboom NSM, Reesink FE, Verwey NA, Kester MI, Teunissen CE, Van De Ven PM et al (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78(1):47\u201354","journal-title":"Neurology"},{"key":"9870_CR9","first-page":"509","volume":"10","author":"M Bruun","year":"2018","unstructured":"Bruun M, Rhodius-Meester HFM, Koikkalainen J, Baroni M, Gjerum L, Lemstra AW et al (2018) Evaluating combinations of diagnostic tests to discriminate different dementia types. Alzheimer\u2019s Dement Diagn Assess Dis Monit 10:509\u2013518","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"issue":"2","key":"9870_CR10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B et al (2005) Simultaneous measurement of \u03b2-amyloid(1\u201342), total Tau, and phosphorylated Tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51(2):336\u2013345","journal-title":"Clin Chem"},{"issue":"9","key":"9870_CR11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","volume":"68","author":"AM Fagan","year":"2011","unstructured":"Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ et al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of \u03b2-amyloid 1\u201342, Total tau, and P-tau181 for identifying alzheimer disease amyloid plaque pathology. Arch Neurol 68(9):1137\u20131144","journal-title":"Arch Neurol"},{"issue":"9","key":"9870_CR12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2005.051201","volume":"51","author":"H Vanderstichele","year":"2005","unstructured":"Vanderstichele H, De Meyer G, Andreasen N, Kostanjevecki V, Wallin A, Olsson A et al (2005) Amino-truncated \u03b2-amyloid 42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Clin Chem 51(9):1650\u20131660","journal-title":"Clin Chem"},{"key":"9870_CR13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.parkreldis.2013.06.008","volume":"19","author":"X Lim","year":"2013","unstructured":"Lim X, Yeo JM, Green A, Pal S (2013) The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies\u2014a systematic review and meta-analysis. Parkinsonism Relat Disord 19:851\u2013858","journal-title":"Parkinsonism Relat Disord"},{"key":"9870_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/567386","author":"B Zhou","year":"2015","unstructured":"Zhou B, Wen M, Yu WF, Zhang CL, Jiao L (2015) The diagnostic and differential diagnosis utility of cerebrospinal fluid \u03b1-synuclein levels in Parkinson\u2019s disease: a meta-analysis. Parkinsons Dis. https:\/\/doi.org\/10.1155\/2015\/567386","journal-title":"Parkinsons Dis"},{"key":"9870_CR15","unstructured":"Llorens F, Kruse N, Schmitz M, Gotzmann N, Golanska E, Th\u00fcne K et al (2016) Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimer\u2019s Dement [Internet]. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1552526016330552"},{"key":"9870_CR16","doi-asserted-by":"crossref","unstructured":"Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N et al (2017) Validation of \u03b1-synuclein as a CSF biomarker for sporadic Creutzfeldt\u2013Jakob disease. Mol Neurobiol [Internet]. https:\/\/link.springer.com\/10.1007\/s12035-017-0479-5","DOI":"10.1007\/s12035-017-0479-5"},{"key":"9870_CR17","doi-asserted-by":"crossref","unstructured":"Oeckl P, Metzger F, Nagl M, von Arnim CAF, Halbgebauer S, Steinacker P et al (2016) Alpha-, beta-, and gamma-synuclein quantification in cerebrospinal fluid by multiple reaction monitoring reveals increased concentrations in Alzheimer\u2019s and Creutzfeldt\u2013Jakob disease but no alteration in synucleinopathies. Mol Cell Proteomics [Internet] 15(10):3126\u20133138. https:\/\/www.mcponline.org\/lookup\/doi\/10.1074\/mcp.M116.059915","DOI":"10.1074\/mcp.M116.059915"},{"issue":"5","key":"9870_CR18","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1007\/s12035-018-1313-4","volume":"56","author":"M Schmitz","year":"2019","unstructured":"Schmitz M, Villar-Piqu\u00e9 A, Llorens F, Gmitterov\u00e1 K, Hermann P, Varges D et al (2019) Cerebrospinal fluid total and phosphorylated \u03b1-synuclein in patients with Creutzfeldt\u2013Jakob disease and synucleinopathy. Mol Neurobiol 56(5):3476\u20133483","journal-title":"Mol Neurobiol"},{"issue":"8","key":"9870_CR19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jalz.2018.02.015","volume":"14","author":"M Shi","year":"2018","unstructured":"Shi M, Tang L, Toledo JB, Ginghina C, Wang H, Aro P et al (2018) Cerebrospinal fluid \u03b1-synuclein contributes to the differential diagnosis of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 14(8):1052\u20131062","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"9870_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S et al (2017) Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimer\u2019s Res Ther 9(1):52","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"9870_CR21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-018-0624-z","volume":"6","author":"D Twohig","year":"2018","unstructured":"Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, M\u00f8ller I et al (2018) The relevance of cerebrospinal fluid \u03b1-synuclein levels to sporadic and familial Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):130","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"9870_CR22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456\u20132477","journal-title":"Brain"},{"key":"9870_CR23","doi-asserted-by":"crossref","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28592453%0A, https:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC5496518","DOI":"10.1212\/WNL.0000000000004058"},{"key":"9870_CR24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"9870_CR25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"issue":"5","key":"9870_CR26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80(5):496\u2013503","journal-title":"Neurology"},{"issue":"6","key":"9870_CR27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853\u2013864","journal-title":"Mov Disord"},{"issue":"9","key":"9870_CR28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676","journal-title":"Neurology"},{"issue":"2","key":"9870_CR29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 43(2):250\u2013260","journal-title":"Neurology."},{"issue":"10","key":"9870_CR30","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease. Brain 132(10):2659\u20132668","journal-title":"Brain"},{"key":"9870_CR31","doi-asserted-by":"crossref","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 12","DOI":"10.1186\/1471-2105-12-77"},{"key":"9870_CR32","doi-asserted-by":"crossref","unstructured":"Passing H, Bablok W (1983) A new biometrical procedure for testing the equality of measurements from two different analytical methods. Clin Chem Lab Med [Internet] 21(11):709\u2013720. https:\/\/www.degruyter.com\/view\/j\/cclm.1983.21.issue-11\/cclm.1983.21.11.709\/cclm.1983.21.11.709.xml","DOI":"10.1515\/cclm.1983.21.11.709"},{"key":"9870_CR33","unstructured":"P\u00e9rez-Enciso M, Tenenhaus M (2003) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet [Internet] 112(5\u20136):581\u2013592. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12607117"},{"key":"9870_CR34","unstructured":"Services USD of H and H (2018) Guidance for industry: bioanalytical method validation guidance for industry bioanalytical method validation. US Food Drug Adm [Internet], 1\u201322. https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm"},{"issue":"2","key":"9870_CR35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B et al (2005) Simultaneous measurement of \u03b2-amyloid (1\u201342), total Tau, and phosphorylated Tau (Thr 181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51(2):336\u2013345","journal-title":"Clin Chem"},{"issue":"4","key":"9870_CR36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"7","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S et al (2011) The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer\u2019s Dement 7(4):386\u2013395","journal-title":"Alzheimer\u2019s Dement"},{"key":"9870_CR37","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o MJ, Silva-Sp\u00ednola A, Santana I, Olmedo V, Nadal A, Le Bastard N et al (2019) Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 11(1)","DOI":"10.1186\/s13195-019-0550-8"},{"key":"9870_CR38","doi-asserted-by":"crossref","unstructured":"Kollhoff AL, Howell JC, Hu WT (2018) Automation vs. experience: Measuring Alzheimer\u2019s beta-amyloid 1\u201342 peptide in the CSF. Front Aging Neurosci 10(AUG)","DOI":"10.3389\/fnagi.2018.00253"},{"key":"9870_CR39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clinbiochem.2019.05.005","volume":"72","author":"V Lifke","year":"2019","unstructured":"Lifke V, Kollmorgen G, Manuilova E, Oelschlaegel T, Hillringhaus L, Widmann M et al (2019) Elecsys\u00ae Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid. Clin Biochem 72:30\u201338","journal-title":"Clin Biochem"},{"key":"9870_CR40","doi-asserted-by":"crossref","unstructured":"Toombs J, Paterson RW, Schott JM, Zetterberg H (2014) Amyloid-beta 42 adsorption following serial tube transfer. Alzheimer\u2019s Res Ther 6(1)","DOI":"10.1186\/alzrt236"},{"issue":"4","key":"9870_CR41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/bmm.12.46","volume":"6","author":"M del Campo","year":"2012","unstructured":"del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH et al (2012) Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update. Biomark Med 6(4):419\u2013430","journal-title":"Biomark Med"},{"issue":"3","key":"9870_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7(3):263\u2013269","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5","key":"9870_CR43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1373\/clinchem.2006.081679","volume":"53","author":"TSM Reijn","year":"2007","unstructured":"Reijn TSM, Rikkert MO, Van Geel WJA, De Jong D, Verbeek MM (2007) Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid \u03b242 and tau proteins. Clin Chem 53(5):859\u2013865","journal-title":"Clin Chem"},{"issue":"4","key":"9870_CR44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, S\u00e1anchez-Valle R, Mitrov\u00e1a E et al (2006) CSF tests in the differential diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 67(4):637\u2013643","journal-title":"Neurology"},{"key":"9870_CR45","first-page":"461","volume":"10","author":"N Kruse","year":"2018","unstructured":"Kruse N, Heslegrave A, Gupta V, Foiani M, Villar-Piqu\u00e9 A, Schmitz M et al (2018) Interlaboratory validation of cerebrospinal fluid \u03b1-synuclein quantification in the diagnosis of sporadic Creutzfeldt\u2013Jakob disease. Alzheimer\u2019s Dement Diagn Assess Dis Monit 10:461\u2013470","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"key":"9870_CR46","doi-asserted-by":"crossref","unstructured":"Lim X, Yeo JM, Green A, Pal S (2013) The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies\u2014a systematic review and meta-analysis. Parkinsonism Relat Disord [Internet] 19(10):851\u2013858. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23886935","DOI":"10.1016\/j.parkreldis.2013.06.008"},{"key":"9870_CR47","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1007\/s12035-018-1313-4","volume":"56","author":"M Schmitz","year":"2018","unstructured":"Schmitz M, Villar-Piqu\u00e9 A, Llorens F, Gmitterov\u00e1 K, Hermann P, Varges D et al (2018) Cerebrospinal fluid total and phosphorylated \u03b1-synuclein in patients with Creutzfeldt\u2013Jakob disease and synucleinopathy. Mol Neurobiol 56:3476\u20133483","journal-title":"Mol Neurobiol"},{"key":"9870_CR48","doi-asserted-by":"crossref","unstructured":"Majbour NK, Chiasserini D, Vaikath NN, Eusebi P, Tokuda T, Van De Berg W et al (2017) Increased levels of CSF total but not oligomeric or phosphorylateed forms of alpha-synuclein in patients diagnosed with probable Alzheimer\u2019s disease. Sci Rep 7","DOI":"10.1038\/srep40263"},{"issue":"6","key":"9870_CR49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2016.09.013","volume":"13","author":"F Llorens","year":"2017","unstructured":"Llorens F, Kruse N, Schmitz M, Gotzmann N, Golanska E, Th\u00fcne K et al (2017) Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimer\u2019s Dement 13(6):710\u2013719","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"9870_CR50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","volume":"133","author":"F Lattanzio","year":"2017","unstructured":"Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I et al (2017) Prion-specific and surrogate CSF biomarkers in Creutzfeldt\u2013Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels. Acta Neuropathol 133(4):559\u2013578","journal-title":"Acta Neuropathol"},{"key":"9870_CR51","doi-asserted-by":"crossref","unstructured":"Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M et al (2019) Diagnosis associated with Tau higher than 1200\u202fpg\/mL: insights from the clinical and laboratory practice. Clin Chim Acta [Internet]. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119318406","DOI":"10.1016\/j.cca.2019.04.081"},{"key":"9870_CR52","doi-asserted-by":"crossref","unstructured":"Zerr I, Schmitz M, Karch A, Villar-Piqu\u00e9 A, Kanata E, Golanska E et al (2018) Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimer\u2019s Dement [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29391125%0A, https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1552526018300025","DOI":"10.1016\/j.jalz.2017.12.008"},{"key":"9870_CR53","doi-asserted-by":"crossref","unstructured":"Landqvist Wald\u00f6 M, Frizell Santillo A, Passant U, Zetterberg H, Rosengren L, Nilsson C et al (2013) Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia. BMC Neurol [Internet] 13(1):54. https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-13-54","DOI":"10.1186\/1471-2377-13-54"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09870-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09870-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09870-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T03:55:33Z","timestamp":1666497333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09870-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9870"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09870-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Written informed consent was obtained from all study participants or their legal guardians. The study was conducted according to the revised Declaration of Helsinki and Good Clinical Practice guidelines, and was approved by all local Ethics committees (Reference numbers 11\/11\/93, 5\/09\/08, 9\/06\/08, 19\/11\/09, Universit\u00e4tsmedizin G\u00f6ttingen, Germany and HUC-43-09, University of Coimbra, Portugal).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}